EUVIMEDEUVIMED entdecken
Crossref

Dual Strategy to Design New Agents Targeting Schistosoma mansoni : Advancing Phenotypic and Sm CB1 Inhibitors for Improved Efficacy

Natalie Fuchs iD, Robert A Zimmermann iD, Marvin Schwickert iD, Annika Gunkel, Collin Zimmer, Mergim Meta iD, Kevin Schwickert, Jennifer Keiser, Cécile Haeberli, Werner Kiefer, Tanja Schirmeister

ACS Infectious Diseases · 2024

DOI: 10.1021/acsinfecdis.4c00020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Natalie Fuchs und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University Mainz, Staudingerweg 5, 55128 Mainz, Germany. Hauptthemen laut MEDLINE: Schistosoma mansoni, Cathepsin B. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Schistosoma mansoniCathepsin BAnimalsSchistosomiasis mansoniDrug DesignHumansPhenotypeStructure-Activity RelationshipAnthelminticsHelminth Proteins

Stichwörter der Autor:innen

cathepsin-B-like proteasecovalent inhibitionschistosomiasisstructure−activity relationship study

Substanzen

Cathepsin BAnthelminticsHelminth Proteins

Autor:innen und Institutionen

  • Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University Mainz, Staudingerweg 5, 55128 Mainz, Germany.
  • Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland.

ORCID-Profile: Natalie Fuchs, Robert A Zimmermann, Marvin Schwickert, Mergim Meta

Zitieren

APA

Fuchs, N., Zimmermann, R. A., Schwickert, M., Gunkel, A., Zimmer, C., Meta, M., Schwickert, K., Keiser, J., Haeberli, C., Kiefer, W., & Schirmeister, T. (2024). Dual Strategy to Design New Agents Targeting Schistosoma mansoni : Advancing Phenotypic and Sm CB1 Inhibitors for Improved Efficacy. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00020

Vancouver

Fuchs N, Zimmermann RA, Schwickert M, Gunkel A, Zimmer C, Meta M, et al. Dual Strategy to Design New Agents Targeting Schistosoma mansoni : Advancing Phenotypic and Sm CB1 Inhibitors for Improved Efficacy. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00020

BibTeX
@article{Fuchs2024,
  author = {Fuchs, Natalie and Zimmermann, Robert A and Schwickert, Marvin and Gunkel, Annika and Zimmer, Collin and Meta, Mergim and Schwickert, Kevin and Keiser, Jennifer and Haeberli, Cécile and Kiefer, Werner and Schirmeister, Tanja},
  title = {Dual Strategy to Design New Agents Targeting Schistosoma mansoni : Advancing Phenotypic and Sm CB1 Inhibitors for Improved Efficacy},
  journal = {ACS Infectious Diseases},
  year = {2024},
  doi = {10.1021/acsinfecdis.4c00020}
}
Kostenlos starten →